• 1
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen JH, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197207.
  • 2
    Takeda S, Elefteriou F, Levasseur R, Liu XY, Zhao LP, Parker KL, Armstrong D, Ducy P, Karsenty G 2002 Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305317.
  • 3
    Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC 2004 Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19: 1924.
  • 4
    Jamal SA, Browner WS, Bauer DC, Cummings SR 1998 Intermittent use of nitrates increases bone mineral density—the study of osteoporotic fractures. J Bone Miner Res 13: 17551759.
  • 5
    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB 2003 Effects of estrogen plus progestin on risk of fracture and bone mineral density—The Women's Health Initiative randomized trial. JAMA 290: 17291738.
  • 6
    Bauer DC 2003 HMG CoA reductase inhibitors and the skeleton: A comprehensive review. Osteoporos Int 14: 273282.
  • 7
    Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MAF, McNeil AR, Gamble GD 2000 Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: A randomized controlled trial. Am J Med 109: 362370.
  • 8
    Kondo A, Togari A 2003 In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am J Physiol 285: E661E667.
  • 9
    Imai Y, Rodan SB, Rodan GA 1988 Effects of retinoic acid on alkaline phosphatase messenger ribonucleic acid, catecholamine receptors, and G proteins in ROS 17/2.8 cells. Endocrinology 122: 456463.
  • 10
    Rodan SB, Rodan GA 1986 Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells. Endocrinology 118: 25102518.
  • 11
    Moore RE, Smith CK II, Bailey CS, Voelkel EF, Tashjian AH Jr 1993 Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 23: 301315.
  • 12
    Kondo A, Mogi M, Koshihara Y, Togari A 2001 Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 61: 319326.
  • 13
    Takeuchi T, Tsuboi T, Arai M, Togari A 2001 Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61: 579586.
  • 14
    Schmitt CP, Obry J, Feneberg R, Veldhuis JD, Mehls O, Ritz E, Schaefer F 2003 Beta 1-adrenergic blockade augments pulsatile PTH secretion in humans. J Am Soc Nephrol 14: 3245.
  • 15
    Dietrich JW, Mundy GR, Raisz LG 1979 Inhibition of bone resorption in tissue culture by membrane-stabilizing drugs. Endocrinology 104: 16441648.
  • 16
    Cherruau M, Facchinetti P, Baroukh B, Saffar JL 1999 Chemical sympathectomy impairs bone resorption in rats: A role for the sympathetic system on bone metabolism. Bone 25: 545551.
  • 17
    Hill EL, Turner R, Elde R 1991 Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44: 747755.
  • 18
    Sandhu HS, Herskovits MS, Singh IJ 1987 Effect of surgical sympathectomy on bone remodeling at rat incisor and molar root sockets. Anat Rec 219: 3238.
  • 19
    Minkowitz B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ 1991 Effects of propranolol on bone metabolism in the rat. J Orthoped Res 9: 869875.